Managing terminal restlessness by Cameron, D
While we can do a lot to ease the discom-
fort and suffering of dying patients, deal-
ing with terminal restlessness still presents
us with a number of challenges. The first
is to recognise the problem, the second is
to discover its cause and the third is to
deal with the situation effectively, compas-
sionately and ethically. Helping the termi-
nally ill to achieve a peaceful, dignified
death is a very satisfying professional task.
In contrast, allowing such a person to
remain restless is not only distressing to
the family, the staff and the other patients
but the grief of the bereaved may also be
compounded by the memory of unre-
lieved suffering.
RECOGNISING THE PROBLEM
As the dying enter the final phase of life,
most wish to slip into a coma and not
wake up again. However, instead of a
peaceful parting, we are sometimes con-
fronted by a restless, noisy, aggressive
patient.‘Dying crazy’ is frightening to all
and can even be dangerous to the staff
and other patients. By recognising this as
a situation that demands urgent attention
and effective treatment, we can avoid an
even greater disaster.
Look for the following features:1
• Sudden onset and fluctuating
course. It is often unexpected.While
the patient may have seemed calm when
you did your morning ward round, as
darkness comes, the mild Dr Jekyl turns
into the monstrous Mr Hyde.
• Inattention. Is the patient easily dis-
tracted? Is he following what you are
saying?
• Muddled thinking. Check orientation
and short-term memory. Is the speech
incoherent or rambling? Are hallucina-
tions or delusions present? 
• Altered level of consciousness . Is the
patient drowsy or over-vigilant and
afraid? Fear is the most common emo-
tional symptom of delirium.
The presence of these features should
alert you to the possibility that the patient
is delirious. Making a definite diagnosis of
delirium is vital so that appropriate action
can be taken. It is important to differenti-
ate between delirium and dementia.
Dementia has a more insidious onset with
progressive impairment of memory, judge-
ment and thinking. In dementia there is
also a lack of fluctuation in symptoms and
no alteration of the level of consciousness.
Delirium has been shown to be present in
the last 2 weeks of life in more than 80%
of patients with advanced cancer and 60%
of terminal AIDS patients.2 Some deliri-
ous patients are inactive with evidence of
confusion, drowsiness and inattention.
Others are overactive with agitation,
aggression and hallucinations. However,
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Terminal restlessness presents many challenges,
not least recognition of the problem and its 
c a u s e s .
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Helping the terminally ill
to achieve a peaceful,
dignified death is a very
satisfying professional
t a s k .
types and may fluctuate from one
extreme to the other. U n f o rt u n at e l y
delirium is frequently not properly
recognised and as a result, it is
often badly managed. In its early
stages delirium may be mistaken
for anxiety, anger, psychosis or
even depression.
DISCOVERING THE CAUSE
Having recognised its presence, is
it really necessary to find the cause
of the delirium? After all, the
patient is dying, the causes are
often multiple and irreversible, and
let us not forget that our resources
are limited. How will it benefit the
dying person? Are we not just pro-
longing dying? These are important
questions. The purpose of looking
for the cause is not just academic
curiosity, it is motivated by the
knowledge that in about a third of
delirious advanced cancer patients,
the cause can be reversed.This is
especially true if the delirium is
drug induced, or the result of
hypercalcaemia, infection or the all
too easily overlooked impacted rec-
tum and urine retention.3
There are several ways of remem-
bering the myriad of possible caus-
es of delirium.The acronym DIM-
TOP is a handy one and has been
slightly modified to suit this topic.
This stands for drugs, infection,
metabolic, trauma, oxygen lack and
pressure.
Drugs
While many drugs may lead to
delirium, only those that are com-
monly used in the care of dying
patients will be considered here.
With the improved management of
the severe pain of advanced cancer
has come a rise in the incidence of
opioid-induced neurotoxicity.4
Although the safety and efficacy of
large doses of morphine has been
adequately demonstrated, we need
to be on the look-out for delirium
associated with myoclonic jerking
and an unexpected increase in
pain.This situation is likely to arise
in patients on high doses of par-
enteral morphine in the presence
of impaired renal function or dehy-
dration. It is due to the accumula-
tion of the metabolites of mor-
phine, especially morphine-3-glu-
curonide (M-3-G) which irritates
the central nervous system and
blocks the analgesic effect of mor-
phine. Discontinue the morphine
or change to another opioid such
as transdermal fentanyl. If appro-
priate, carefully rehydrate the
patient and prescribe a benzo-
diazepine such as midazolam for a
short while to stop the jerking.
These measures should rapidly
correct the problem.
High doses of steroids such as dex-
amethasone are commonly used in
advanced cancer especially for the
palliative treatment of cachexia,
anorexia, cerebral tumours, spinal
cord compression and neuropathic
pain. In susceptible individuals
high-dose steroids can lead to agi-
tation, paranoia and insomnia.5
Various drugs such as metoclo-
pramide, haloperidol, ondansetron
and cyclizine are very effective in
treating nausea in terminal
patients. Occasionally motor rest-
lessness (akathisia) due to the
blocking of dopamine or delirium
due to anticholinergic side-effects
may occur.6 Withdrawal of the
offending drug is usually all that is
needed. In fact it is good practice
to withdraw all drugs that are not
absolutely necessary for the dying
patient’s comfort.When a patient
develops symptoms suggestive of
delirium one of the first things to
do is to carefully review the
patient’s prescription.
Infection
While the management of infection
in a ‘normal’ patient is usually
straightforward, in the context of
the terminally ill there are several
other factors to consider.
Hypostatic pneumonia has rightly
been called ‘the old man’s friend’.
We need to be certain that treat-
ment of infection will help towards
the goal of comfort care.While it is
usually helpful to treat a bladder
infection if it is causing distress, we
need to consider whether the treat-
ment of other infections is merely
prolonging suffering. In such cir-
cumstances, it would be better to
‘give death a chance’. Robert
Twycross, one of the doyens of pal-
liative medicine in Britain, has
rightly stated: ‘A doctor has neither
the duty nor the right to prescribe
a lingering death.’7
However, in the context of the cur-
rent AIDS epidemic we need a
slightly different approach.
Tuberculosis, Pneumocystis carinii
pneumonia and other pneumonias,
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come a rise in the
incidence of opioid-
induced 
n e u r o t o x i c i t y .
In susceptible indi -
viduals high-dose
steroids can lead to
agitation, paranoia
and insomnia.
cryptococcal meningitis and severe
candidiasis may all contribute to
delirium and will usually respond
to specific treatment. These infec-
tions should always be excluded
before embarking on comfort care
only in the dying AIDS patient.
METABOLIC
Hypercalcaemia is the most com-
mon metabolic abnormality in
advanced cancer and often pre-
sents as delirium.8 It occurs espe-
cially in breast, squamous cell, lung
and renal carcinomas as well as in
mutiple myeloma. Treatment with
fluid replacement and bisphospho-
nates is worth considering in the
context of a patient who still has a
good performance status.
Most dying patients stop eating
and even drinking at the end of
life. Apart from the use of par-
enteral fluids in the specific situa-
tions outlined above, their routine
use has no place in dying patients.
Intravenous fluids and the resulting
hyponatraemia have even been
implicated as a cause of delirium.
Many researchers have shown that
dehydration rather than causing
distress, actually facilitates patient
comfort through decreased con-
sciousness.3
The delirium of hepatic or renal
failure in a terminal patient is also
not reversible.
Trauma
A fall and a chronic subdural
haematoma is a possibility in frail
terminal patients.
Lack of oxygen
When delirium is due to hypoxia,
oxygen seldom results in any
improvement in patients with
advanced cancer. Sedation is more
appropriate.3
Pressure
Intracranial tumours and raised
intracranial pressure may cause
delirium and may initially respond
to high doses of steroids. Following
a good response, the steroids can
be tapered down to a low mainte-
nance dose or even withdrawn.
DEALING WITH THE
SITUATION
Having recognised the problem
and, where possible, established
the cause, it remains to deal with
the situation effectively, compas-
sionately and ethically.
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c o n s c i o u s n e s s .
Indication Drug Dosage Route*
Calming Haloperidol 1.5 - 20 mg/24 h PO, PR, SC
an agitated 2.5 mg bolus over 2-3 min IV
patient Repeat after 30 min if needed
Give a double dose after a further 
30 min if necessary
20 - 30 mg/24 h SC infusion
Sedation Midazolam 2.5 - 5 mg bolus over 2 - 3 min, repeat IV
of an until effective sedation is achieved
aggressive 10 - 20 mg SC
patient 30 - 100 mg/24 h SC infusion
Deep Propofol 20 - 50 mg bolus over 5 min IV
sedation of 5 - 70 mg/h IV infusion
a violent 
patient
Deep Phenobarbital 200 mg SC/IM
sedation 800 - 1 600 mg/24 h SC infusion
PO = per os; PR = per rectum;  SC = subcutaneous; IV = intravenous; IM = intramuscular.
*In most cases the SC route is preferable. It is almost as rapidly effective as IV without the risks or the difficulty of finding a vein in an aggressive patient. An
SC infusion is also easy to maintain and does not require splinting or restraining of the patient’s arm.
Table I. Drugs for managing delirium in terminal patients2,9
• Respond to the situation calmly
and ensure the safety of the
patient and the staff .
• Carefully explain what is hap-
pening to the relatives and if pos-
sible, even to the patient. It is
important that the family under-
stand that the patient is not
‘mad’ and that the prognosis is
very poor with no curative
options.They should understand
the need to maintain sedation
until the end.
• Where there is aggression ensure
that an adequate number of staff
are constantly with the patient
until the situation is under con-
trol.
• Use appropriate drugs in effec-
tive doses.This is not the time to
be hesitant or tentative.2 The
choice of drugs is determined by
the desired intent (Table I).
• If the patient is agitated and
needs to be calmed, the best
drug is haloperidol. Used in
correct doses it is effective, safe
and versatile.
• If aggressive, the patient needs
to be sedated. A good choice is
a benzodiazepine such as mida-
zolam.
• In an extreme situation with a
violent patient, it may be nec-
essary to sedate the patient by
means of an anaesthetic agent
such as propofol or a barbitu-
rate. Ongoing sedation by
means of an infusion pump
will be needed.While some
reject the use of such measures
as bordering on euthanasia, the
clear intent is to make the
patient manageable and not to
cause death. Sedation will,
however, have to be maintained
at an appropriate level until
death occurs.
• The question of artificial feeding
and hydration needs to be care-
fully considered together with
the family. There is no evidence
that either contribute to the
comfort of the dying patient, and
thus in most cases both are
unnecessary.10 In the few cases
where there is a definite reason
for giving fluids parenterally,
1.5 l/24 hours can be given by
the SC route (hypodermoclysis).
This, together with good mouth
care, is adequate under these cir-
cumstances.
There is a wide range in the
reported prevalence of the use of
sedation for refractory delirium in
the medical literature. Sedation is
required in about 25% of terminal
patients in palliative care units and
of these about 50% will be for
delirium.11
References available on request.
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IN A NUTSHELL
Delirium is common in dying
patients. 
To recognise the problem look for
features such as inattention, mud-
dled thinking, altered level of con -
sciousness of recent onset and
with a fluctuating course.
Although in many cases delirium
in dying patients is irreversible,
infection, hypercalcaemia, faecal
impaction, urinary retention and
certain drug interactions may be
reversible. 
If aggressive and violent, use
appropriate drugs in effective
doses to adequately sedate the
patient.
Carefully explain the cause of the
strange behaviour to the patient’s
family and help them to under-
stand the poor prognosis and the
need for effective sedation.
SINGLE SUTURE
Prophylactic oophorectomy can help women at risk of cancer
Women who have the BRAC1 or BRAC2 germ-line mutations have an increased risk of breast and ovarian
cancer. Research was conducted to determine whether oophorectomy would reduce the risk of coelomic
epithelial cancer and breast cancer in women who carry these mutations. A total of 259 women who had
undergone oophorectomy, and 292 matched controls who had not undergone the procedure, were enrolled in
the study.The results showed that bilateral oophorectomy reduced the risk of coelomic epithelial cancer and
breast cancer in women with BRCA1 and BRCA2 mutations (Rebbeck TR et al. N Engl J Med 2002; 346:
1616-1622).
